{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T20:17:07Z","timestamp":1793305027106,"version":"4.5.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,3,7]],"date-time":"2019-03-07T00:00:00Z","timestamp":1551916800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004817","name":"Lund University Medical Faculty Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004817","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002426","name":"Fondazione Telethon","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002426","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.drudis.2019.03.004","type":"journal-article","created":{"date-parts":[[2019,3,12]],"date-time":"2019-03-12T22:46:37Z","timestamp":1552430797000},"page":"1637-1643","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":67,"title":["Drug delivery to retinal photoreceptors"],"prefix":"10.1016","volume":"24","author":[{"given":"Erico","family":"Himawan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Ekstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matej","family":"Buzgo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter","family":"Gaillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Einar","family":"Stef\u00e1nsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Marigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9439-1553","authenticated-orcid":false,"given":"Thorsteinn","family":"Loftsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7355-5742","authenticated-orcid":false,"given":"Fran\u00e7ois","family":"Paquet-Durand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2019.03.004_bib0005","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1511\/2003.11.28","article-title":"How the retina works","volume":"91","author":"Kolb","year":"2003","journal-title":"Am. Sci."},{"key":"10.1016\/j.drudis.2019.03.004_bib0010","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1080\/09286586.2017.1281426","article-title":"The economic impact of blindness in Europe","volume":"24","author":"Chakravarthy","year":"2017","journal-title":"Ophthal. Epidemiol."},{"key":"10.1016\/j.drudis.2019.03.004_bib0015","first-page":"459","article-title":"Organotypic retinal explant cultures as in vitro alternative for diabetic retinopathy studies","volume":"33","author":"Valdes","year":"2016","journal-title":"ALTEX"},{"key":"10.1016\/j.drudis.2019.03.004_bib0020","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ajo.2017.05.016","article-title":"Physical activity and age-related macular degeneration: a systematic literature review and meta-analysis","volume":"180","author":"McGuinness","year":"2017","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.drudis.2019.03.004_bib0025","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.tig.2004.12.001","article-title":"Light in retinitis pigmentosa","volume":"21","author":"Kennan","year":"2005","journal-title":"Trends Genet."},{"key":"10.1016\/j.drudis.2019.03.004_bib0030","first-page":"2015","article-title":"Spare the rods, save the cones in aging and age-related maculopathy","volume":"41","author":"Curcio","year":"2000","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.drudis.2019.03.004_bib0035","doi-asserted-by":"crossref","first-page":"598","DOI":"10.2174\/156652412800620048","article-title":"Neuroprotective strategies for the treatment of inherited photoreceptor degeneration","volume":"12","author":"Trifunovic","year":"2012","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.drudis.2019.03.004_bib0040","series-title":"Histology of the Human Eye: an Atlas and Textbook","year":"1971"},{"key":"10.1016\/j.drudis.2019.03.004_bib0045","doi-asserted-by":"crossref","first-page":"E2997","DOI":"10.1073\/pnas.1718792115","article-title":"Combination of cGMP analogue and drug delivery system provides functional protection in hereditary retinal degeneration","volume":"115","author":"Vighi","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.drudis.2019.03.004_bib0050","article-title":"Suprachoroidal injection of triamcinolone acetonide, CLS-TA, for macular edema due to noninfectious uveitis: a randomized, Phase 2 study (DOGWOOD)","author":"Yeh","year":"2018","journal-title":"Retina"},{"key":"10.1016\/j.drudis.2019.03.004_bib0055","doi-asserted-by":"crossref","first-page":"4155","DOI":"10.1167\/iovs.17-22402","article-title":"Subretinal injection for gene therapy does not cause clinically significant outer nuclear layer thinning in normal primate foveae","volume":"58","author":"Ochakovski","year":"2017","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.drudis.2019.03.004_bib0060","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/aos.12803","article-title":"Topical dexamethasone gamma-cyclodextrin nanoparticle eye drops increase visual acuity and decrease macular thickness in diabetic macular oedema","volume":"93","author":"Ohira","year":"2015","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.drudis.2019.03.004_bib0065","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1159\/000431143","article-title":"Routes for drug delivery to the eye and retina: intravitreal injections","volume":"55","author":"Meyer","year":"2016","journal-title":"Dev. Ophthalmol."},{"key":"10.1016\/j.drudis.2019.03.004_bib0070","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1136\/bjophthalmol-2015-307707","article-title":"Incidence and clinical features of post-injection endophthalmitis according to diagnosis","volume":"100","author":"Rayess","year":"2015","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.drudis.2019.03.004_bib0075","series-title":"Natural Polymer Drug Delivery Systems","first-page":"33","article-title":"Nanoparticles types, classification, characterization, fabrication methods, and drug delivery applications","author":"Bhatia","year":"2016"},{"key":"10.1016\/j.drudis.2019.03.004_bib0080","article-title":"Nanoceria inhibit the development and promote the regression of pathologic retinal neovascularization in the Vldlr knockout mouse","volume":"6","author":"Zhou","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.drudis.2019.03.004_bib0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0000038","article-title":"Efficient non-viral ocular gene transfer with compacted DNA nanoparticles","volume":"1","author":"Farjo","year":"2006","journal-title":"PLoS One"},{"key":"10.1016\/j.drudis.2019.03.004_bib0090","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jconrel.2013.01.004","article-title":"Specific uptake of folate-decorated triamcinolone-encapsulating nanoparticles by retinal pigment epithelium cells enhances and prolongs antiangiogenic activity","volume":"167","author":"Suen","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.drudis.2019.03.004_bib0095","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jconrel.2015.01.001","article-title":"Light-responsive nanoparticle depot to control release of a small molecule angiogenesis inhibitor in the posterior segment of the eye","volume":"200","author":"Huu","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.drudis.2019.03.004_bib0100","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.1167\/iovs.05-0165","article-title":"Vitreous: a barrier to nonviral ocular gene therapy","volume":"46","author":"Peeters","year":"2005","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.drudis.2019.03.004_bib0105","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1016\/j.biomaterials.2012.01.030","article-title":"The movement of self-assembled amphiphilic polymeric nanoparticles in the vitreous and retina after intravitreal injection","volume":"33","author":"Koo","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.drudis.2019.03.004_bib0110","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s11095-008-9745-6","article-title":"Investigating the movement of intravitreal human serum albumin nanoparticles in the vitreous and retina","volume":"26","author":"Kim","year":"2009","journal-title":"Pharm. Res."},{"key":"10.1016\/j.drudis.2019.03.004_bib0115","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ijpharm.2017.04.010","article-title":"Cyclodextrins and topical drug delivery to the anterior and posterior segments of the eye","volume":"531","author":"Loftsson","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.drudis.2019.03.004_bib0120","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0163-7258(89)90049-1","article-title":"The pharmacology of antiglaucoma drugs","volume":"43","author":"Sugrue","year":"1989","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.drudis.2019.03.004_bib0125","doi-asserted-by":"crossref","first-page":"5257","DOI":"10.1021\/nl502275s","article-title":"Nanoparticle-assisted targeted delivery of eye-specific genes to eyes significantly improves the vision of blind mice in vivo","volume":"14","author":"Rajala","year":"2014","journal-title":"Nano Lett."},{"key":"10.1016\/j.drudis.2019.03.004_bib0130","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.7150\/thno.15230","article-title":"Cell-specific promoters enable lipid-based nanoparticles to deliver genes to specific cells of the retina in vivo","volume":"6","author":"Wang","year":"2016","journal-title":"Theranostics"},{"key":"10.1016\/j.drudis.2019.03.004_bib0135","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s11095-018-2519-x","article-title":"Topical drug delivery to the posterior segment of the eye: addressing the challenge of preclinical to clinical translation","volume":"35","author":"Rodrigues","year":"2018","journal-title":"Pharm. Res."},{"key":"10.1016\/j.drudis.2019.03.004_bib0140","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1016\/j.addr.2005.09.004","article-title":"Topical and systemic drug delivery to the posterior segments","volume":"57","author":"Hughes","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.drudis.2019.03.004_bib0145","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.jddst.2018.04.007","article-title":"Topical drug delivery to the posterior segment of the eye: dexamethasone concentrations in various eye tissues after topical administration for up to 15days to rabbits","volume":"45","author":"Johannsdottir","year":"2018","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.drudis.2019.03.004_bib0150","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1002\/jps.23994","article-title":"Enhanced doxorubicin delivery to the brain administered through glutathione PEGylated liposomal doxorubicin (2B3-101) as compared with generic Caelyx,((R))\/Doxil((R))\u2014a cerebral open flow microperfusion pilot study","volume":"103","author":"Birngruber","year":"2014","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.drudis.2019.03.004_bib0155","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ddtec.2016.09.003","article-title":"Glutathione conjugation dose-dependently increases brain-specific liposomal drug delivery in vitro and in vivo","volume":"20","author":"Maussang","year":"2016","journal-title":"Drug Discov. Today Technol."},{"key":"10.1016\/j.drudis.2019.03.004_bib0160","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1517\/17425247.2010.490554","article-title":"Systemic delivery of therapeutics to neuronal tissues: a barrier modulation approach","volume":"7","author":"Campbell","year":"2010","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.drudis.2019.03.004_bib0165","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3389\/fncel.2016.00020","article-title":"Brain and retinal pericytes: origin, function and role","volume":"10","author":"Trost","year":"2016","journal-title":"Front. Cell Neurosci."},{"key":"10.1016\/j.drudis.2019.03.004_bib0170","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.jconrel.2012.01.019","article-title":"Liposomes for intravitreal drug delivery: a state of the art","volume":"161","author":"Bochot","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.drudis.2019.03.004_bib0175","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.bbrc.2015.04.088","article-title":"Effective delivery of recombinant proteins to rod photoreceptors via lipid nanovesicles","volume":"461","author":"Asteriti","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.drudis.2019.03.004_bib0180","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/978-1-62703-080-9_26","article-title":"Barrier modulation in drug delivery to the retina","volume":"935","author":"Campbell","year":"2013","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.drudis.2019.03.004_bib0185","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.preteyeres.2017.09.003","article-title":"Manipulating ocular endothelial tight junctions: applications in treatment of retinal disease pathology and ocular hypertension","volume":"62","author":"Campbell","year":"2018","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.drudis.2019.03.004_bib0190","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.1500472","article-title":"Autoregulated paracellular clearance of amyloid-beta across the blood\u2013brain barrier","volume":"1","author":"Keaney","year":"2015","journal-title":"Sci. Adv."},{"key":"10.1016\/j.drudis.2019.03.004_bib0195","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/emmm.201100126","article-title":"Systemic low-molecular weight drug delivery to pre-selected neuronal regions","volume":"3","author":"Campbell","year":"2011","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.drudis.2019.03.004_bib0200","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ijpharm.2017.02.035","article-title":"Enhanced ocular efficacy of topically-delivered dorzolamide with nanostructured mucoadhesive microparticles","volume":"522","author":"Park","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.drudis.2019.03.004_bib0205","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ejpb.2016.10.006","article-title":"Solid lipid nanoparticles as promising tool for intraocular tobramycin delivery: pharmacokinetic studies on rabbits","volume":"109","author":"Chetoni","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.drudis.2019.03.004_bib0210","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3109\/08982104.2014.881850","article-title":"Preparation, characterization and evaluation of novel elastic nano-sized niosomes (ethoniosomes) for ocular delivery of prednisolone","volume":"24","author":"Gaafar","year":"2014","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.drudis.2019.03.004_bib0215","doi-asserted-by":"crossref","first-page":"9540","DOI":"10.1021\/ja102595j","article-title":"UV and near-IR triggered release from polymeric nanoparticles","volume":"132","author":"Fomina","year":"2010","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.drudis.2019.03.004_bib0220","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.biomaterials.2016.03.004","article-title":"Structural recovery of the retina in a retinoschisin-deficient mouse after gene replacement therapy by solid lipid nanoparticles","volume":"90","author":"Apaolaza","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.drudis.2019.03.004_bib0225","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jconrel.2013.11.004","article-title":"A novel cationic niosome formulation for gene delivery to the retina","volume":"174","author":"Puras","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.drudis.2019.03.004_bib0230","doi-asserted-by":"crossref","first-page":"275103","DOI":"10.1088\/0957-4484\/25\/27\/275103","article-title":"Two cholesterol derivative-based PEGylated liposomes as drug delivery system, study on pharmacokinetics and drug delivery to retina","volume":"25","author":"Geng","year":"2014","journal-title":"Nanotechnology"},{"key":"10.1016\/j.drudis.2019.03.004_bib0235","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.1021\/nn305958y","article-title":"Targeted intraceptor nanoparticle therapy reduces angiogenesis and fibrosis in primate and murine macular degeneration","volume":"7","author":"Luo","year":"2013","journal-title":"ACS Nano"},{"key":"10.1016\/j.drudis.2019.03.004_bib0240","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1167\/iovs.13-13599","article-title":"Systemic treatment with glutathione PEGylated liposomal methylprednisolone (2B3-201) improves therapeutic efficacy in a model of ocular inflammation","volume":"55","author":"Reijerkerk","year":"2014","journal-title":"Invest. Ophthalmol. Vis. Sci."}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644618305117?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644618305117?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T12:44:30Z","timestamp":1761223470000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644618305117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":48,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S1359644618305117"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2019.03.004","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug delivery to retinal photoreceptors","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2019.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}